Logo Image

Shorts

What is the Role of PCI in LS-SCLC?
0:41
What is the Role of PCI in LS-SCLC?
5 months ago
by
Raj Singh, MD
Combining KRAS Inhibition With Immunotherapy in NSCLC
1:01
Combining KRAS Inhibition With Immunotherapy in NSCLC
6 months ago
by
Jamie E. Chaft, MD
Evolving Clinical Utility of ctDNA in Upper GI Cancer Care
0:54
Evolving Clinical Utility of ctDNA in Upper GI Cancer Care
6 months ago
by
Ryan H. Moy, MD, PhD
Dr Raj Singh on Advances in Head and Neck Cancer Therapy
0:36
Dr Raj Singh on Advances in Head and Neck Cancer Therapy
6 months ago
by
Raj Singh, MD
Unlocking the Secrets of Breast Cancer Mutations
0:46
Unlocking the Secrets of Breast Cancer Mutations
6 months ago
by
Pedram Razavi, MD, PhD
The Huge Unmet Need: CNS Efficacy in Lung Cancer Drugs
1:05
The Huge Unmet Need: CNS Efficacy in Lung Cancer Drugs
6 months ago
by
Helena Yu, MD
The Danger of Relying Solely on Negative ctDNA Tests
0:49
The Danger of Relying Solely on Negative ctDNA Tests
6 months ago
by
Catherine T. Haring, MD
Can Myeloma Treatment Be Done at Home?
0:57
Can Myeloma Treatment Be Done at Home?
6 months ago
by
Sikander Ailawadhi, MD
MRD Alerts: How Soon Will Imaging Confirm Progression?
0:34
MRD Alerts: How Soon Will Imaging Confirm Progression?
6 months ago
by
Rutika Mehta, MD, MPH
The Future of Targeted Therapy in Mesothelioma
0:33
The Future of Targeted Therapy in Mesothelioma
6 months ago
by
Michael Offin, MD
Dr Kittai on The Role of MRD Testing in CLL
0:39
Dr Kittai on The Role of MRD Testing in CLL
6 months ago
by
Adam Kittai, MD(+1 more)
How Proton Therapy is Revolutionizing Cancer Treatment
0:33
How Proton Therapy is Revolutionizing Cancer Treatment
6 months ago
by
Charles Simone, MD
Why Patient Preference Matters in CLL Treatment
0:41
Why Patient Preference Matters in CLL Treatment
6 months ago
by
Adam Kittai, MD(+1 more)
Low ctDNA May Signal Aggressive Tumor in Head and Neck Cancer
1:00
Low ctDNA May Signal Aggressive Tumor in Head and Neck Cancer
6 months ago
by
Catherine T. Haring, MD
The Biggest Unmet Needs in Lung Cancer
1:03
The Biggest Unmet Needs in Lung Cancer
6 months ago
by
Adam Schoenfeld, MD
Talking MRD and ctDNA With Patients
0:34
Talking MRD and ctDNA With Patients
6 months ago
by
Rutika Mehta, MD, MPH
Who Should Get Neoadjuvant Therapy in RCC
0:30
Who Should Get Neoadjuvant Therapy in RCC
6 months ago
by
Naomi Haas, MD
Don't Believe The Google Prognosis: New Hope For Glioblastoma
0:30
Don't Believe The Google Prognosis: New Hope For Glioblastoma
6 months ago
by
Chibawanye Ene, MD, PhD
Why We Need To Look Outside the Brain to Treat Tumors
0:32
Why We Need To Look Outside the Brain to Treat Tumors
6 months ago
by
Chibawanye Ene, MD, PhD
Adjuvant Therapy in Non-Clear Cell RCC
0:44
Adjuvant Therapy in Non-Clear Cell RCC
6 months ago
by
Naomi Haas, MD
The Prognostic Potential of MRD/ctDNA in Metastatic GE Cancer
0:52
The Prognostic Potential of MRD/ctDNA in Metastatic GE Cancer
6 months ago
by
Rutika Mehta, MD, MPH
Don't Over-Treat Based on Risk Scores
0:50
Don't Over-Treat Based on Risk Scores
6 months ago
by
Rami Komrokji, MD
Targeted: On Location at Memorial Sloan Kettering Cancer Center
0:17
Targeted: On Location at Memorial Sloan Kettering Cancer Center
6 months ago
by
Helena Yu, MD(+2 more)
Understanding MDS Staging and the Path to Cure
0:42
Understanding MDS Staging and the Path to Cure
6 months ago
by
Rami Komrokji, MD
ctDNA & MRD: Smarter Therapy Decisions in Metastatic GE Cancer
0:49
ctDNA & MRD: Smarter Therapy Decisions in Metastatic GE Cancer
6 months ago
by
Rutika Mehta, MD, MPH
Combining CELMoDs and Cell Therapies in Myeloma
0:46
Combining CELMoDs and Cell Therapies in Myeloma
6 months ago
by
Sagar Lonial, MD, FACP
Balancing Therapy and QOL With MRD Testing in Gastroesophageal Cancer
0:49
Balancing Therapy and QOL With MRD Testing in Gastroesophageal Cancer
6 months ago
by
Rutika Mehta, MD, MPH
A Mass in the Right-Sided Kidney
0:35
A Mass in the Right-Sided Kidney
6 months ago
by
Pavlos Msaouel, MD, PhD
Menin Inhibitors Could Redefine AML Frontline Therapy
0:47
Menin Inhibitors Could Redefine AML Frontline Therapy
6 months ago
by
Richard Stone, MD
Setting a New Standard in EGFR+ Lung Cancer
0:42
Setting a New Standard in EGFR+ Lung Cancer
6 months ago
by
Nicolas Girard, MD, PhD